ArticleScience and engineering ethics2020
Retraction: The "Other Face" of Research Collaboration?
Article in Science and engineering ethics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Analysis of Retracted Publications in Medical Literature Due to Ethical Violations.Journal of Korean medical science · 2023Article
- Retractions, Fake Peer Reviews, and Paper Mills.Journal of Korean medical science · 2021Article
- Retracted articles in the biomedical literature from Indian authors.Scientometrics · 2021Article
- Research ethics: a profile of retractions from world class universities.Scientometrics · 2021Article
- Does open data boost journal impact: evidence from Chinese economics.Scientometrics · 2021Article
- The Effects of Anti-corruption Campaign on Research Grant Reimbursement: Regression Discontinuity Evidence from China.Science and engineering ethics · 2020Article
- Comparing like with like: China ranks first in SCI-indexed research articles since 2018.Scientometrics · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The last two decades have witnessed the rising prevalence of both co-publishing and retraction. Focusing on research collaboration, this paper utilizes a unique dataset to investigate factors contributing to retraction probability and elapsed time between publication and retraction. Data analysis reveals that the majority of retracted papers are multi-authored and that repeat offenders are collaboration prone. Yet, all things being equal, collaboration, in and of itself, does not increase the likelihood of producing flawed or fraudulent research, at least in the form of retraction. That holds for all retractions and also retractions due to falsification, fabrication, and plagiarism (FFP). The research also finds that publications with authors from elite universities are less likely to be retracted, which is particularly true for retractions due to FFP. China stands out with the fastest retracting speed compared to other countries. Possible explanations, limitations, and policy implications are also discussed.
Indexed as
Identifiers
32215814What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.